[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Quetiapine Fumarate Consumption Market Report

October 2018 | 164 pages | ID: 264BF1358C1EN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Quetiapine Fumarate market for 2018-2023.
Quetiapine Fumarate is an atypical antipsychotic drug used to treat psychiatric disorders such as schizophrenia, bipolar disorder and depression. It may be used alone or in combination with other psychiatric medications. It is taken orally, and is available only by prescription, under the supervision of a medical practitioner.
The Quetiapine Fumarate was developed by AstraZeneca from 1992 to 1996. It was first approved by the FDA in 1997.
The product is invented and first produced in the UK by AstraZeneca. AstraZeneca is also the leader of the Quetiapine Fumarate base drugs.
The Average gross of the industry is over 40%. However, since there are new companies coming into the area, the gross is declining in the last several years.

Over the next five years, LPI(LP Information) projects that Quetiapine Fumarate will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Quetiapine Fumarate market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Immediate Release Tablets
  • Extended Release Tablets
Segmentation by application:
  • Application 1
  • Application 2
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • AstraZeneca
  • Intas
  • TAPI
  • Accord
  • Hexal
  • Dr.Reddy's
  • Lupin
  • Sun Pharmaceutical
  • Hunan Dongting Pharm
  • SuZhou NO.4 Phamaceutical Factory
  • Fuan Pharmaceutical
  • Zhejiang Supor Pharmaceuticals
  • Zhejiang Huahai Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES
  • To study and analyze the global Quetiapine Fumarate consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Quetiapine Fumarate market by identifying its various subsegments.
  • Focuses on the key global Quetiapine Fumarate manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Quetiapine Fumarate with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Quetiapine Fumarate submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 GLOBAL QUETIAPINE FUMARATE CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Quetiapine Fumarate Consumption 2013-2023
  2.1.2 Quetiapine Fumarate Consumption CAGR by Region
2.2 Quetiapine Fumarate Segment by Type
  2.2.1 Immediate Release Tablets
  2.2.2 Extended Release Tablets
2.3 Quetiapine Fumarate Consumption by Type
  2.3.1 Global Quetiapine Fumarate Consumption Market Share by Type (2013-2018)
  2.3.2 Global Quetiapine Fumarate Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Quetiapine Fumarate Sale Price by Type (2013-2018)
2.4 Quetiapine Fumarate Segment by Application
  2.4.1 Application
  2.4.2 Application
2.5 Quetiapine Fumarate Consumption by Application
  2.5.1 Global Quetiapine Fumarate Consumption Market Share by Application (2013-2018)
  2.5.2 Global Quetiapine Fumarate Value and Market Share by Application (2013-2018)
  2.5.3 Global Quetiapine Fumarate Sale Price by Application (2013-2018)

3 GLOBAL QUETIAPINE FUMARATE BY PLAYERS

3.1 Global Quetiapine Fumarate Sales Market Share by Players
  3.1.1 Global Quetiapine Fumarate Sales by Players (2016-2018)
  3.1.2 Global Quetiapine Fumarate Sales Market Share by Players (2016-2018)
3.2 Global Quetiapine Fumarate Revenue Market Share by Players
  3.2.1 Global Quetiapine Fumarate Revenue by Players (2016-2018)
  3.2.2 Global Quetiapine Fumarate Revenue Market Share by Players (2016-2018)
3.3 Global Quetiapine Fumarate Sale Price by Players
3.4 Global Quetiapine Fumarate Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Quetiapine Fumarate Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Quetiapine Fumarate Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 QUETIAPINE FUMARATE BY REGIONS

4.1 Quetiapine Fumarate by Regions
  4.1.1 Global Quetiapine Fumarate Consumption by Regions
  4.1.2 Global Quetiapine Fumarate Value by Regions
4.2 Americas Quetiapine Fumarate Consumption Growth
4.3 APAC Quetiapine Fumarate Consumption Growth
4.4 Europe Quetiapine Fumarate Consumption Growth
4.5 Middle East & Africa Quetiapine Fumarate Consumption Growth

5 AMERICAS

5.1 Americas Quetiapine Fumarate Consumption by Countries
  5.1.1 Americas Quetiapine Fumarate Consumption by Countries (2013-2018)
  5.1.2 Americas Quetiapine Fumarate Value by Countries (2013-2018)
5.2 Americas Quetiapine Fumarate Consumption by Type
5.3 Americas Quetiapine Fumarate Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Quetiapine Fumarate Consumption by Countries
  6.1.1 APAC Quetiapine Fumarate Consumption by Countries (2013-2018)
  6.1.2 APAC Quetiapine Fumarate Value by Countries (2013-2018)
6.2 APAC Quetiapine Fumarate Consumption by Type
6.3 APAC Quetiapine Fumarate Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Quetiapine Fumarate by Countries
  7.1.1 Europe Quetiapine Fumarate Consumption by Countries (2013-2018)
  7.1.2 Europe Quetiapine Fumarate Value by Countries (2013-2018)
7.2 Europe Quetiapine Fumarate Consumption by Type
7.3 Europe Quetiapine Fumarate Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Quetiapine Fumarate by Countries
  8.1.1 Middle East & Africa Quetiapine Fumarate Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Quetiapine Fumarate Value by Countries (2013-2018)
8.2 Middle East & Africa Quetiapine Fumarate Consumption by Type
8.3 Middle East & Africa Quetiapine Fumarate Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Quetiapine Fumarate Distributors
10.3 Quetiapine Fumarate Customer

11 GLOBAL QUETIAPINE FUMARATE MARKET FORECAST

11.1 Global Quetiapine Fumarate Consumption Forecast (2018-2023)
11.2 Global Quetiapine Fumarate Forecast by Regions
  11.2.1 Global Quetiapine Fumarate Forecast by Regions (2018-2023)
  11.2.2 Global Quetiapine Fumarate Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Quetiapine Fumarate Forecast by Type
11.8 Global Quetiapine Fumarate Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 AstraZeneca
  12.1.1 Company Details
  12.1.2 Quetiapine Fumarate Product Offered
  12.1.3 AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 AstraZeneca News
12.2 Intas
  12.2.1 Company Details
  12.2.2 Quetiapine Fumarate Product Offered
  12.2.3 Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Intas News
12.3 TAPI
  12.3.1 Company Details
  12.3.2 Quetiapine Fumarate Product Offered
  12.3.3 TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 TAPI News
12.4 Accord
  12.4.1 Company Details
  12.4.2 Quetiapine Fumarate Product Offered
  12.4.3 Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Accord News
12.5 Hexal
  12.5.1 Company Details
  12.5.2 Quetiapine Fumarate Product Offered
  12.5.3 Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Hexal News
12.6 Dr.Reddy's
  12.6.1 Company Details
  12.6.2 Quetiapine Fumarate Product Offered
  12.6.3 Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Dr.Reddy's News
12.7 Lupin
  12.7.1 Company Details
  12.7.2 Quetiapine Fumarate Product Offered
  12.7.3 Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Lupin News
12.8 Sun Pharmaceutical
  12.8.1 Company Details
  12.8.2 Quetiapine Fumarate Product Offered
  12.8.3 Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Sun Pharmaceutical News
12.9 Hunan Dongting Pharm
  12.9.1 Company Details
  12.9.2 Quetiapine Fumarate Product Offered
  12.9.3 Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Hunan Dongting Pharm News
12.10 SuZhou NO.4 Phamaceutical Factory
  12.10.1 Company Details
  12.10.2 Quetiapine Fumarate Product Offered
  12.10.3 SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 SuZhou NO.4 Phamaceutical Factory News
12.11 Fuan Pharmaceutical
12.12 Zhejiang Supor Pharmaceuticals
12.13 Zhejiang Huahai Pharmaceutical

13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Quetiapine Fumarate
Table Product Specifications of Quetiapine Fumarate
Figure Quetiapine Fumarate Report Years Considered
Figure Market Research Methodology
Figure Global Quetiapine Fumarate Consumption Growth Rate 2013-2023 (MT)
Figure Global Quetiapine Fumarate Value Growth Rate 2013-2023 ($ Millions)
Table Quetiapine Fumarate Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Immediate Release Tablets
Table Major Players of Immediate Release Tablets
Figure Product Picture of Extended Release Tablets
Table Major Players of Extended Release Tablets
Table Global Consumption Sales by Type (2013-2018)
Table Global Quetiapine Fumarate Consumption Market Share by Type (2013-2018)
Figure Global Quetiapine Fumarate Consumption Market Share by Type (2013-2018)
Table Global Quetiapine Fumarate Revenue by Type (2013-2018) ($ million)
Table Global Quetiapine Fumarate Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Quetiapine Fumarate Value Market Share by Type (2013-2018)
Table Global Quetiapine Fumarate Sale Price by Type (2013-2018)
Figure Quetiapine Fumarate Consumed in Application
Figure Global Quetiapine Fumarate Market: Application 1 (2013-2018) (MT)
Figure Global Quetiapine Fumarate Market: Application 1 (2013-2018) ($ Millions)
Figure Global Application 1 YoY Growth ($ Millions)
Figure Quetiapine Fumarate Consumed in Application
Figure Global Quetiapine Fumarate Market: Application 2 (2013-2018) (MT)
Figure Global Quetiapine Fumarate Market: Application 2 (2013-2018) ($ Millions)
Figure Global Application 2 YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Quetiapine Fumarate Consumption Market Share by Application (2013-2018)
Figure Global Quetiapine Fumarate Consumption Market Share by Application (2013-2018)
Table Global Quetiapine Fumarate Value by Application (2013-2018)
Table Global Quetiapine Fumarate Value Market Share by Application (2013-2018)
Figure Global Quetiapine Fumarate Value Market Share by Application (2013-2018)
Table Global Quetiapine Fumarate Sale Price by Application (2013-2018)
Table Global Quetiapine Fumarate Sales by Players (2016-2018) (MT)
Table Global Quetiapine Fumarate Sales Market Share by Players (2016-2018)
Figure Global Quetiapine Fumarate Sales Market Share by Players in 2016
Figure Global Quetiapine Fumarate Sales Market Share by Players in 2017
Table Global Quetiapine Fumarate Revenue by Players (2016-2018) ($ Millions)
Table Global Quetiapine Fumarate Revenue Market Share by Players (2016-2018)
Figure Global Quetiapine Fumarate Revenue Market Share by Players in 2016
Figure Global Quetiapine Fumarate Revenue Market Share by Players in 2017
Table Global Quetiapine Fumarate Sale Price by Players (2016-2018)
Figure Global Quetiapine Fumarate Sale Price by Players in 2017
Table Global Quetiapine Fumarate Manufacturing Base Distribution and Sales Area by Players
Table Players Quetiapine Fumarate Products Offered
Table Quetiapine Fumarate Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Quetiapine Fumarate Consumption by Regions 2013-2018 (MT)
Table Global Quetiapine Fumarate Consumption Market Share by Regions 2013-2018
Figure Global Quetiapine Fumarate Consumption Market Share by Regions 2013-2018
Table Global Quetiapine Fumarate Value by Regions 2013-2018 ($ Millions)
Table Global Quetiapine Fumarate Value Market Share by Regions 2013-2018
Figure Global Quetiapine Fumarate Value Market Share by Regions 2013-2018
Figure Americas Quetiapine Fumarate Consumption 2013-2018 (MT)
Figure Americas Quetiapine Fumarate Value 2013-2018 ($ Millions)
Figure APAC Quetiapine Fumarate Consumption 2013-2018 (MT)
Figure APAC Quetiapine Fumarate Value 2013-2018 ($ Millions)
Figure Europe Quetiapine Fumarate Consumption 2013-2018 (MT)
Figure Europe Quetiapine Fumarate Value 2013-2018 ($ Millions)
Figure Middle East & Africa Quetiapine Fumarate Consumption 2013-2018 (MT)
Figure Middle East & Africa Quetiapine Fumarate Value 2013-2018 ($ Millions)
Table Americas Quetiapine Fumarate Consumption by Countries (2013-2018) (MT)
Table Americas Quetiapine Fumarate Consumption Market Share by Countries (2013-2018)
Figure Americas Quetiapine Fumarate Consumption Market Share by Countries in 2017
Table Americas Quetiapine Fumarate Value by Countries (2013-2018) ($ Millions)
Table Americas Quetiapine Fumarate Value Market Share by Countries (2013-2018)
Figure Americas Quetiapine Fumarate Value Market Share by Countries in 2017
Table Americas Quetiapine Fumarate Consumption by Type (2013-2018) (MT)
Table Americas Quetiapine Fumarate Consumption Market Share by Type (2013-2018)
Figure Americas Quetiapine Fumarate Consumption Market Share by Type in 2017
Table Americas Quetiapine Fumarate Consumption by Application (2013-2018) (MT)
Table Americas Quetiapine Fumarate Consumption Market Share by Application (2013-2018)
Figure Americas Quetiapine Fumarate Consumption Market Share by Application in 2017
Figure United States Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure United States Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Canada Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Canada Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Mexico Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Mexico Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Table APAC Quetiapine Fumarate Consumption by Countries (2013-2018) (MT)
Table APAC Quetiapine Fumarate Consumption Market Share by Countries (2013-2018)
Figure APAC Quetiapine Fumarate Consumption Market Share by Countries in 2017
Table APAC Quetiapine Fumarate Value by Countries (2013-2018) ($ Millions)
Table APAC Quetiapine Fumarate Value Market Share by Countries (2013-2018)
Figure APAC Quetiapine Fumarate Value Market Share by Countries in 2017
Table APAC Quetiapine Fumarate Consumption by Type (2013-2018) (MT)
Table APAC Quetiapine Fumarate Consumption Market Share by Type (2013-2018)
Figure APAC Quetiapine Fumarate Consumption Market Share by Type in 2017
Table APAC Quetiapine Fumarate Consumption by Application (2013-2018) (MT)
Table APAC Quetiapine Fumarate Consumption Market Share by Application (2013-2018)
Figure APAC Quetiapine Fumarate Consumption Market Share by Application in 2017
Figure China Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure China Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Japan Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Japan Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Korea Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Korea Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Southeast Asia Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure India Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure India Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Australia Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Australia Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Table Europe Quetiapine Fumarate Consumption by Countries (2013-2018) (MT)
Table Europe Quetiapine Fumarate Consumption Market Share by Countries (2013-2018)
Figure Europe Quetiapine Fumarate Consumption Market Share by Countries in 2017
Table Europe Quetiapine Fumarate Value by Countries (2013-2018) ($ Millions)
Table Europe Quetiapine Fumarate Value Market Share by Countries (2013-2018)
Figure Europe Quetiapine Fumarate Value Market Share by Countries in 2017
Table Europe Quetiapine Fumarate Consumption by Type (2013-2018) (MT)
Table Europe Quetiapine Fumarate Consumption Market Share by Type (2013-2018)
Figure Europe Quetiapine Fumarate Consumption Market Share by Type in 2017
Table Europe Quetiapine Fumarate Consumption by Application (2013-2018) (MT)
Table Europe Quetiapine Fumarate Consumption Market Share by Application (2013-2018)
Figure Europe Quetiapine Fumarate Consumption Market Share by Application in 2017
Figure Germany Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Germany Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure France Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure France Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure UK Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure UK Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Italy Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Italy Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Russia Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Russia Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Spain Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Spain Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Quetiapine Fumarate Consumption by Countries (2013-2018) (MT)
Table Middle East & Africa Quetiapine Fumarate Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Quetiapine Fumarate Consumption Market Share by Countries in 2017
Table Middle East & Africa Quetiapine Fumarate Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Quetiapine Fumarate Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Quetiapine Fumarate Value Market Share by Countries in 2017
Table Middle East & Africa Quetiapine Fumarate Consumption by Type (2013-2018) (MT)
Table Middle East & Africa Quetiapine Fumarate Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Quetiapine Fumarate Consumption Market Share by Type in 2017
Table Middle East & Africa Quetiapine Fumarate Consumption by Application (2013-2018) (MT)
Table Middle East & Africa Quetiapine Fumarate Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Quetiapine Fumarate Consumption Market Share by Application in 2017
Figure Egypt Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Egypt Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure South Africa Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure South Africa Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Israel Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Israel Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure Turkey Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure Turkey Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Quetiapine Fumarate Consumption Growth 2013-2018 (MT)
Figure GCC Countries Quetiapine Fumarate Value Growth 2013-2018 ($ Millions)
Table Quetiapine Fumarate Distributors List
Table Quetiapine Fumarate Customer List
Figure Global Quetiapine Fumarate Consumption Growth Rate Forecast (2018-2023) (MT)
Figure Global Quetiapine Fumarate Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Quetiapine Fumarate Consumption Forecast by Countries (2018-2023) (MT)
Table Global Quetiapine Fumarate Consumption Market Forecast by Regions
Table Global Quetiapine Fumarate Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Quetiapine Fumarate Value Market Share Forecast by Regions
Figure Americas Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Americas Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure APAC Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure APAC Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Europe Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Europe Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Middle East & Africa Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Middle East & Africa Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure United States Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure United States Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Canada Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Canada Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Mexico Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Mexico Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Brazil Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Brazil Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure China Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure China Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Japan Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Japan Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Korea Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Korea Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Southeast Asia Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Southeast Asia Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure India Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure India Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Australia Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Australia Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Germany Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Germany Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure France Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure France Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure UK Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure UK Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Italy Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Italy Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Russia Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Russia Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Spain Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Spain Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Egypt Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Egypt Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure South Africa Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure South Africa Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Israel Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Israel Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure Turkey Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure Turkey Quetiapine Fumarate Value 2018-2023 ($ Millions)
Figure GCC Countries Quetiapine Fumarate Consumption 2018-2023 (MT)
Figure GCC Countries Quetiapine Fumarate Value 2018-2023 ($ Millions)
Table Global Quetiapine Fumarate Consumption Forecast by Type (2018-2023) (MT)
Table Global Quetiapine Fumarate Consumption Market Share Forecast by Type (2018-2023)
Table Global Quetiapine Fumarate Value Forecast by Type (2018-2023) ($ Millions)
Table Global Quetiapine Fumarate Value Market Share Forecast by Type (2018-2023)
Table Global Quetiapine Fumarate Consumption Forecast by Application (2018-2023) (MT)
Table Global Quetiapine Fumarate Consumption Market Share Forecast by Application (2018-2023)
Table Global Quetiapine Fumarate Value Forecast by Application (2018-2023) ($ Millions)
Table Global Quetiapine Fumarate Value Market Share Forecast by Application (2018-2023)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AstraZeneca Quetiapine Fumarate Market Share (2016-2018)
Table Intas Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intas Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Intas Quetiapine Fumarate Market Share (2016-2018)
Table TAPI Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TAPI Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure TAPI Quetiapine Fumarate Market Share (2016-2018)
Table Accord Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Accord Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Accord Quetiapine Fumarate Market Share (2016-2018)
Table Hexal Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hexal Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hexal Quetiapine Fumarate Market Share (2016-2018)
Table Dr.Reddy's Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dr.Reddy's Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Dr.Reddy's Quetiapine Fumarate Market Share (2016-2018)
Table Lupin Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lupin Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lupin Quetiapine Fumarate Market Share (2016-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sun Pharmaceutical Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sun Pharmaceutical Quetiapine Fumarate Market Share (2016-2018)
Table Hunan Dongting Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hunan Dongting Pharm Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hunan Dongting Pharm Quetiapine Fumarate Market Share (2016-2018)
Table SuZhou NO.4 Phamaceutical Factory Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Sales, Revenue, Price and Gross Margin (2016-2018)
Figure SuZhou NO.4 Phamaceutical Factory Quetiapine Fumarate Market Share (2016-2018)
Table Fuan Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zhejiang Supor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors


More Publications